IRA Investment Strategies

4DMT announces favorable 2-year results from its PRISM Phase 2b clinical trial in wet AMD, indicating potential for a new treatment option.

• Gold IRA Markets Team
• July 19, 2026

Vireo Growth Inc. has finalized the acquisition of a Pennsylvania dispensary license, expanding its presence in the state’s medical cannabis market.

• Gold IRA Markets Team
• July 18, 2026

Costa Rica has announced a new initiative to export its agricultural products to millions of European consumers, boosting trade and local farmers.

• Gold IRA Markets Team
• July 18, 2026

CAMP4 Therapeutics announced an inducement grant under Nasdaq Rule 5635(c)(4), supporting its NASDAQ listing and growth plans.

• Gold IRA Markets Team
• July 18, 2026

Topicus.com Inc. announces it will release its Q2 financial results on August 10, 2024, providing investors with upcoming financial insights.

• Gold IRA Markets Team
• July 17, 2026

Approximately 300 lives have been saved through organ donations in the first six months of 2026, according to official data. This highlights ongoing efforts to improve organ donation rates.

• Gold IRA Markets Team
• July 17, 2026

Credit Suisse Asset Management Income Fund, Inc. announced a name change, reflecting a rebranding effort. Details on the new name and reasons are forthcoming.

• Gold IRA Markets Team
• July 17, 2026

Dairy industry entrepreneurs can now apply for the Dairy Runway program, supporting innovative startups in the dairy sector. Applications close soon.

• Gold IRA Markets Team
• July 16, 2026

Sands plans to release its second quarter 2026 financial results, with details expected soon, as investors await the company’s latest performance update.

• Gold IRA Markets Team
• July 16, 2026

United Airlines exceeds Wall Street forecasts for Q2 and raises full-year 2026 EPS guidance despite rising fuel costs, boosting investor confidence.

• Gold IRA Markets Team
• July 16, 2026